News Releases

Moffitt Cancer Center and ITUS Corporation Request Meeting with FDA Regarding Ovarian Cancer CAR-T Therapy

August 1, 2018

ITUS Corporation Releases Results for Cchek™ Breast Cancer Study

July 30, 2018

ITUS Corporation Announces Second Commercial Focus for Cchek™ will be Breast Cancer

July 6, 2018

ITUS to Ring the NASDAQ Closing Bell on July 5th

June 29, 2018

ITUS Accelerates Schedule for its CAR T Therapy and Provides Update

June 26, 2018

ITUS Corporation Announces First Commercial Focus for Cchek™ will be Prostate Cancer

June 13, 2018

ITUS Corporation to Present at the 3rd Annual Disruptive Growth & Healthcare Conference Hosted by RHK Capital and ReedSmith

May 1, 2018

ITUS Presentation to Special Meeting of Stockholders

April 2, 2018

ITUS and Serametrix Announce Results of a Blinded Prostate Cancer Study

March 27, 2018

ITUS Announces Issuance of Second Key Cancer Detection Technology Patent

March 26, 2018

Latest News & Events

Sep 8, 2025

Anixa Biosciences and Moffitt Cancer Center Complete Dosing of Fourth Cohort in Ovarian Cancer CAR-T Clinical Trial; Multiple Patients Surpassing Median Expected Survival

Read More...

Sep 2, 2025

Anixa Biosciences Announces Time Change for Presentation at the H.C. Wainwright 27th Annual Global Investment Conference

Read More...

Aug 25, 2025

Anixa Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Read More...